Key Drivers
- Cash Flow Rebound
- Elevated Leverage
- Impairment Risk
AIAI Summary
ACHC is now a leveraged execution story: investors should wait for sustained proof that its ~3,000 new beds can ramp into cash-generative EBITDA and support deleveraging, as legal scrutiny, reimbursement friction, and thin interest coverage could quickly erode equity value if monetization slips.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Flow Rebound
- •Elevated Leverage
- •Impairment Risk
ACHC's quarterly turnaround in profitability and free cash flow is encouraging, but high leverage, weak interest coverage, and balance-sheet impairment risk warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Recent pullback
- •Key range
- •Neutral momentum
ACHC is mixed after a last-month gain, with a break above $29.00 favoring a retest of $30.20–$30.60, while a drop below $27.00 signals renewed downside risk.
Price fell roughly 7% from the $30.58
Sentiment & News
Key News Insights:
- •Revenue Growth
- •BlackRock Stake
- •Legal Scrutiny
Acadia Healthcare shows solid demand, growth, and institutional support, but labor-margin pressure and ongoing legal scrutiny create elevated risk.
ACHC's upside potential is tempered by investigation-related uncertainty and profitability pressures
Similar Companies in Healthcare
Other companies in the same sector with AI ratings